1. Home
  2. HRTX vs CERS Comparison

HRTX vs CERS Comparison

Compare HRTX & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRTX
  • CERS
  • Stock Information
  • Founded
  • HRTX 1983
  • CERS 1991
  • Country
  • HRTX United States
  • CERS United States
  • Employees
  • HRTX N/A
  • CERS N/A
  • Industry
  • HRTX Biotechnology: Pharmaceutical Preparations
  • CERS EDP Services
  • Sector
  • HRTX Health Care
  • CERS Technology
  • Exchange
  • HRTX Nasdaq
  • CERS Nasdaq
  • Market Cap
  • HRTX 276.1M
  • CERS 265.7M
  • IPO Year
  • HRTX 1987
  • CERS 1997
  • Fundamental
  • Price
  • HRTX $1.33
  • CERS $1.24
  • Analyst Decision
  • HRTX Strong Buy
  • CERS Strong Buy
  • Analyst Count
  • HRTX 2
  • CERS 2
  • Target Price
  • HRTX $4.50
  • CERS $3.50
  • AVG Volume (30 Days)
  • HRTX 2.2M
  • CERS 1.2M
  • Earning Date
  • HRTX 08-08-2025
  • CERS 08-05-2025
  • Dividend Yield
  • HRTX N/A
  • CERS N/A
  • EPS Growth
  • HRTX N/A
  • CERS N/A
  • EPS
  • HRTX N/A
  • CERS N/A
  • Revenue
  • HRTX $149,694,000.00
  • CERS $192,510,000.00
  • Revenue This Year
  • HRTX $12.08
  • CERS $24.95
  • Revenue Next Year
  • HRTX $12.57
  • CERS $11.88
  • P/E Ratio
  • HRTX N/A
  • CERS N/A
  • Revenue Growth
  • HRTX 9.78
  • CERS 13.25
  • 52 Week Low
  • HRTX $1.04
  • CERS $1.12
  • 52 Week High
  • HRTX $2.68
  • CERS $2.39
  • Technical
  • Relative Strength Index (RSI)
  • HRTX 28.25
  • CERS 41.74
  • Support Level
  • HRTX $1.31
  • CERS $1.25
  • Resistance Level
  • HRTX $1.47
  • CERS $1.38
  • Average True Range (ATR)
  • HRTX 0.11
  • CERS 0.07
  • MACD
  • HRTX -0.04
  • CERS -0.00
  • Stochastic Oscillator
  • HRTX 19.72
  • CERS 15.79

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: